Huang CH - Search Results

1

Afatinib treatment in a large real-world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation.

Huang CH, Ju JS, Chiu TH, Huang AC, Tung PH, Wang CC, Liu CY, Chung FT, Fang YF, Guo YK, Kuo CS, Yang CT. Huang CH, et al. Among authors: huang ac. Int J Cancer. 2022 Feb 15;150(4):626-635. doi: 10.1002/ijc.33821. Epub 2021 Oct 26. Int J Cancer. 2022. PMID: 34558665 Free article.

2

Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib.

Kuo CS, Huang CH, Liu CY, Pavlidis S, Ko HW, Chung FT, Lin TY, Wang CL, Guo YK, Yang CT. Kuo CS, et al. Among authors: huang ch. Target Oncol. 2019 Aug;14(4):433-440. doi: 10.1007/s11523-019-00657-1. Target Oncol. 2019. PMID: 31346928

3

Factors Associated with Exercise-Induced Desaturation in Patients with Chronic Obstructive Pulmonary Disease.

Chang CH, Lin HC, Yang CH, Gan ST, Huang CH, Chung FT, Hu HC, Lin SM, Chang CH. Chang CH, et al. Among authors: huang ch. Int J Chron Obstruct Pulmon Dis. 2020 Oct 23;15:2643-2652. doi: 10.2147/COPD.S272511. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 33122902 Free PMC article.

4

First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer.

Huang AC, Huang CH, Ju JS, Chiu TH, Tung PH, Wang CC, Liu CY, Chung FT, Fang YF, Guo YK, Kuo CS, Yang CT. Huang AC, et al. Among authors: huang ch. Ther Adv Med Oncol. 2021 Jul 31;13:17588359211035710. doi: 10.1177/17588359211035710. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34377157 Free PMC article.

5

Comparisons of Outcomes between Patients with Direct and Indirect Acute Respiratory Distress Syndrome Receiving Extracorporeal Membrane Oxygenation.

Chiu LC, Chuang LP, Lin SW, Li HH, Leu SW, Chang KW, Huang CH, Chiu TH, Wu HP, Tsai FC, Huang CC, Hu HC, Kao KC. Chiu LC, et al. Among authors: huang cc, huang ch. Membranes (Basel). 2021 Aug 22;11(8):644. doi: 10.3390/membranes11080644. Membranes (Basel). 2021. PMID: 34436407 Free PMC article.

6

Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation.

Kuo CS, Chiu TH, Tung PH, Huang CH, Ju JS, Huang AC, Wang CC, Ko HW, Hsu PC, Fang YF, Guo YK, Yang CT. Kuo CS, et al. Among authors: huang ac, huang ch. Cancers (Basel). 2022 Jan 9;14(2):316. doi: 10.3390/cancers14020316. Cancers (Basel). 2022. PMID: 35053480 Free PMC article.

7

The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis.

Chiu TH, Tung PH, Huang CH, Ju JS, Huang AC, Wang CC, Ko HW, Hsu PC, Fang YF, Guo YK, Kuo CS, Yang CT. Chiu TH, et al. Among authors: huang ac, huang ch. Sci Rep. 2022 Mar 15;12(1):4398. doi: 10.1038/s41598-022-08449-w. Sci Rep. 2022. PMID: 35292755 Free PMC article.

8

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC.

Ju JS, Huang AC, Tung PH, Huang CH, Chiu TH, Wang CC, Ko HW, Chung FT, Hsu PC, Fang YF, Guo YK, Kuo CS, Yang CT. Ju JS, et al. Among authors: huang ac, huang ch. Sci Rep. 2023 Nov 21;13(1):20323. doi: 10.1038/s41598-023-45815-8. Sci Rep. 2023. PMID: 37989860 Free PMC article.

9

Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.

Tung PH, Chiu TH, Huang AC, Ju JS, Huang CH, Wang CC, Ko HW, Chung FT, Hsu PC, Fang YF, Guo YK, Kuo CS, Yang CT. Tung PH, et al. Among authors: huang ac, huang ch. Ther Adv Med Oncol. 2024 Jan 19;16:17588359231222604. doi: 10.1177/17588359231222604. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38249338 Free PMC article.

10

Tumor Volume Reduction Rate to Induction Chemotherapy is a Prognostic Factor for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Retrospective Cohort Study.

Lin TC, Huang CH, Lien MY, Cheng FM, Li KC, Lin CY, Lin YC, Liang JA, Wang TH. Lin TC, et al. Among authors: huang ch. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221107714. doi: 10.1177/15330338221107714. Technol Cancer Res Treat. 2022. PMID: 35770906 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,413 results

Search Page